Bio-Rad Labs Inc. A buy Wells Fargo & Company
Start price
16.06.23
/
50%
€355.00
Target price
16.06.24
€502.10
Performance (%)
-25.32%
End price
17.06.24
€265.10
Summary
This prediction ended on 17.06.24 with a price of €265.10. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.32%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio-Rad Labs Inc. A | -0.763% | -0.763% | 27.974% | -10.857% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $550.00 price target on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Wells_Fargo___Compan for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€364.80
07.08.23
07.08.23
€477.33
07.08.24
07.08.24
-20.83%
08.08.24
08.08.24
